Trial Profile
An Open-label Study to Characterize the Pharmacokinetics and Safety of Oxycodone Hydrochloride q12h Controlled-Release (ORF) Tablets in Pediatric Patients Aged 6 to 16 Years Inclusive, Who Require Opioid Analgesia.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Acute pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Purdue Pharma
- 14 Jul 2019 Trial has been completed in UK, according to European Clinical Trials Database record.
- 22 Mar 2012 Additional trial location added as reported by European Clinical Trials Database.
- 22 Mar 2012 This trial is not authorised in United Kingdom.